312 related articles for article (PubMed ID: 19928582)
1. [Cytochrome P450 isoenzymes in metabolism of endo- and exogenic compounds].
Wiśniewska A; Mazerska Z
Postepy Biochem; 2009; 55(3):259-71. PubMed ID: 19928582
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
Schroer K; Kittelmann M; Lütz S
Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
[TBL] [Abstract][Full Text] [Related]
3. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
[TBL] [Abstract][Full Text] [Related]
4. [Role of human cytochrome P-450 enzymes in the metabolism of xenobiotics].
Monostory K; Vereczkey L
Acta Pharm Hung; 1995 Sep; 65(5):147-56. PubMed ID: 7484161
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
[TBL] [Abstract][Full Text] [Related]
6. Probing the world of cytochrome P450 enzymes.
Frye RF
Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
Shimada T; El-Bayoumy K; Upadhyaya P; Sutter TR; Guengerich FP; Yamazaki H
Cancer Res; 1997 Nov; 57(21):4757-64. PubMed ID: 9354437
[TBL] [Abstract][Full Text] [Related]
8. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
Fang J; McKay G; Song J; Remillrd A; Li X; Midha K
Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183
[TBL] [Abstract][Full Text] [Related]
11. Rate-limiting steps in cytochrome P450 catalysis.
Guengerich FP
Biol Chem; 2002 Oct; 383(10):1553-64. PubMed ID: 12452431
[TBL] [Abstract][Full Text] [Related]
12. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
Shimada T; Yamazaki H; Mimura M; Wakamiya N; Ueng YF; Guengerich FP; Inui Y
Drug Metab Dispos; 1996 May; 24(5):515-22. PubMed ID: 8723730
[TBL] [Abstract][Full Text] [Related]
13. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
McGinnity DF; Parker AJ; Soars M; Riley RJ
Drug Metab Dispos; 2000 Nov; 28(11):1327-34. PubMed ID: 11038161
[TBL] [Abstract][Full Text] [Related]
14. Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
Huskey SW; Dean DC; Miller RR; Rasmusson GH; Chiu SH
Drug Metab Dispos; 1995 Oct; 23(10):1126-35. PubMed ID: 8654202
[TBL] [Abstract][Full Text] [Related]
15. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli.
McGinnity DF; Griffin SJ; Moody GC; Voice M; Hanlon S; Friedberg T; Riley RJ
Drug Metab Dispos; 1999 Sep; 27(9):1017-23. PubMed ID: 10460801
[TBL] [Abstract][Full Text] [Related]
16. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes].
Filimonova AA; Ziganshin AU; Ziganshina LE
Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639
[TBL] [Abstract][Full Text] [Related]
17. Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research.
Masimirembwa CM; Otter C; Berg M; Jönsson M; Leidvik B; Jonsson E; Johansson T; Bäckman A; Edlund A; Andersson TB
Drug Metab Dispos; 1999 Oct; 27(10):1117-22. PubMed ID: 10497136
[TBL] [Abstract][Full Text] [Related]
18. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
Yu L; Waxman DJ
Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.
Nakajima M; Ohyama K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 1999 Jul; 27(7):792-7. PubMed ID: 10383922
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of ethyl carbamate by pulmonary cytochrome P450 and carboxylesterase isozymes: involvement of CYP2E1 and hydrolase A.
Forkert PG; Lee RP
Toxicol Appl Pharmacol; 1997 Oct; 146(2):245-54. PubMed ID: 9344892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
